Lungs May Hold the Secret to Long-Term Allergy Protection, Study Finds

Respiratory allergies are surging worldwide, driven by worsening air pollution and climate change. Now, a new study from France's Pasteur Institute has uncovered how the lungs themselves may hold the key to long-term protection against these reactions. The findings challenge long-held assumptions about how immunological memory works in allergies.

The research focused on fibroblasts, a type of connective tissue cell in the lungs. Unlike traditional immune cells, these fibroblasts were found to store immunological memory after exposure to microbial fragments. When mice were first exposed to bacterial or viral particles, their fibroblasts underwent epigenetic changes that blocked allergic reactions for months.

In experiments, mice given microbial fragments before allergen exposure remained protected for at least six weeks. Those without this initial exposure developed severe lung hypersensitivity, with reactions worsening dramatically upon re-exposure. The protection lasted over three months, suggesting a durable mechanism.

The study's original finding overturns the idea that only immune cells retain memory for allergies. Instead, structural lung cells appear to play a central role. Scientists believe this discovery could lead to new ways of preventing respiratory allergies, which have spiked in countries like China, India, and parts of Europe over the past decade.

Rising pollution and longer pollen seasons have made allergies more common and severe. The team's work suggests that controlled exposure to microbial fragments might train the lungs to resist allergic triggers long-term.

The findings open up potential clinical strategies for tackling respiratory allergies. By targeting fibroblasts, treatments could create lasting protection rather than just managing symptoms. Further research will explore how this mechanism might be applied in humans to curb the growing burden of allergies.